Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity

Taha, Dhiaa A. and Zgair, Atheer and Lee, Jong Bong and de Moor, Cornelia H. and Barrett, David A. and Bruce, Kimberley D. and Sungelo, Mitchell and Eckel, Robert H. and Gershkovich, Pavel (2017) Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity. European Journal of Pharmaceutical Sciences, 100 . pp. 163-175. ISSN 1879-0720

[img] PDF - Repository staff only until 16 January 2018. - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution Non-commercial No Derivatives.
Download (1MB)

Abstract

The association of lipophilic statins with plasma lipoproteins in the presence of disturbed acid-base balance can modify the pharmacokinetics and tissue distribution of these drugs, resulting in alteration in their efficacy and toxicity profiles. The purpose of this study is to elucidate the role of hyperlipidaemia alone or in combination with acidosis/alkalosis in the development and potentiation of statin-induced myotoxicity. Statins association with plasma lipoproteins was examined under conditions of physiological and altered pH levels. The effect of this association on cellular uptake and myotoxicity of statins was also assessed at different pH levels using C2C12 cells that overexpress lipoprotein lipase. Lipophilic simvastatin displayed considerable association with the non-polar lipoprotein fractions (triglyceride-rich lipoproteins and Low-density lipoprotein). This association contributed to increased cellular uptake of simvastatin by C2C12 cells through lipoprotein lipasemediated process, resulting in enhanced muscle toxicity in hyperlipidaemic conditions. Furthermore, a combination of low pH environment (representing acidosis) and hyperlipidaemia increased the association of simvastatin with plasma lipoproteins causing potentiation of cellular uptake and myotoxicity of this drug. Comorbidities such as hyperlipidaemia, especially when coincident with acidosis, can enhance statin-associated muscle toxicity, and therefore require extra caution by prescribing clinicians. Hydrophilic rather than lipophilic statins could be a preferable choice in this patient population.

Item Type: Article
Keywords: Acidosis, Chylomicrons, Hyperlipidemia, Lipoproteins, Myotoxicity, Statins
Schools/Departments: University of Nottingham, UK > Faculty of Science > School of Pharmacy
Identification Number: https://doi.org/10.1016/j.ejps.2017.01.018
Depositing User: Eprints, Support
Date Deposited: 17 Jan 2017 09:34
Last Modified: 13 Feb 2017 18:43
URI: http://eprints.nottingham.ac.uk/id/eprint/39896

Actions (Archive Staff Only)

Edit View Edit View